United States Retail Pharmacy Market Introduction and Overview
According to SPER Market Research, the United States Retail Pharmacy Market is estimated to reach USD XX billion by 2033 with a CAGR XX%.
The report includes an in-depth analysis of the United States Retail Pharmacy Market, including market size and trends, product mix, distribution channels, and supplier analysis. The retail pharmacy is an independently location that offers the general public branded and generic medications with or without a prescription. The growth of pharmacy retail chains has facilitated the integration of numerous healthcare components, hence improving customer convenience in the purchase of pharmaceuticals and other products.
- The internet pharmacy Medly Pharmacy said in June 2021 that it intended to purchase the Pharmaca chain in order to increase its market share in thirty various areas.
- The online pharmacy PharmEasy purchased the ePharmacy Medlife in May 2021 in an effort to increase its market share and establish a stronger presence in the sector. PharmEasy now controls between 60% and 70% of the Indian ePharmacy market as a result of this purchase.
Market Opportunities and Challenges
Opportunities: Growing Need for Personalized Treatment > Specialized pharmaceutical goods are in high demand due to the increased emphasis on personalized care, which entails customizing medical therapy for each patient based on their distinct genetic composition. Retail pharmacies are essential to the supply of these customized drugs, which propels the market's expansion.
Growing Over-the-Counter (OTC) Market: One major factor driving the pharmacy retail industry is the growing demand for over-the-counter pharmaceuticals, which is being driven by a rise in self-medication habits and a move toward preventative healthcare.
Challenges: Strictly regulated environment Health authorities and licensing bodies put strict restrictions and compliance requirements on the pharmacy retail market, which works within a complex regulatory environment. Market participants may face difficulties complying with these requirements, such as extra expenses, drawn-out procedures, and possible legal and reputational issues. Extreme Competition The retail pharmacy industry is characterized by intense competition from a wide range of domestic and foreign competitors. One way to counter new entrants or smaller companies in the market is to compete with well-established pharmacy chains, internet sellers, and other healthcare providers. In this competitive environment, differentiating themselves, retaining client loyalty, and guaranteeing competitive pricing are crucial issues.
Market Competitive Landscape
The competitive landscape of the pharmacy retail sector includes information broken down by rival. A summary of the business, its financials, its revenue, its market potential, and its investment in research and development are all provided. Some of the market key players are CVS Health, Walgreens Boots Alliance, Inc., Albertsons Companies, Dirk Rossmann GmbH, Rite Aid Corp., The Jean Coutu Group, Loblaws Inc.
Scope of the Report:
Report Metric | Details |
Market size available for years | 2020-2033 |
Base year considered | 2023 |
Forecast period | 2024-2033 |
Segments covered | By Type, By Drug Type, By End User
|
Regions covered | Eastern, Western, Northern, Southern
|
Companies Covered | CVS Health, Walgreens Boots Alliance, Inc., Albertsons Companies, Dirk Rossmann GmbH, Rite Aid Corp., The Jean Coutu Group, Loblaws Inc. |
COVID-19 Impact on United States Retail Pharmacy Market
The COVID-19 epidemic has significantly changed customer behavior and industry dynamics in the US retail pharmacy sector. Lockdowns, social distancing tactics, and virus fears have led to a noticeable change in the supply of pharmaceuticals and healthcare items toward online shopping and home delivery. Traditional brick-and-mortar pharmacies are being prompted to invest in strong digital infrastructure and improve their online presence due to the spike in demand for digital pharmacy services, which has also spurred the adoption of telemedicine and e-pharmacy platforms.
Key Target Audience:
- Health Care Associations
- Hospitals
- Pharmaceutical Distributors
- Pharmaceutical Manufacturers
- Pharmacy Chains
Our in-depth analysis of the United States Retail Pharmacy Market includes the following segments:
By Type: |
Online
Offline
|
By Drug Type: |
Generic
Over the counter (OTC)
Patented
|
By End User: |
Equipment retail
Drug retail
Health products retail
Chemical medicine retail
Medicinal materials retail
Proprietary chinese medicine retail
|
Key Topics Covered in the Report:
- United States Retail Pharmacy Market Size (FY’2024-FY’2033)
- Overview of United States Retail Pharmacy Market
- Segmentation of United States Retail Pharmacy Market By Type (Online, Offline)
- Segmentation of United States Retail Pharmacy Market By Drug Type (Generic
- Over the counter, Patented)
- Segmentation of United States Retail Pharmacy Market By End User (Equipment retail, Drug retail, Health products retail, Chemical medicine retail, Medicinal materials retail, Proprietary chinese medicine retail, Others)
- Expansion Analysis of United States Retail Pharmacy Market
- Problems and Obstacles in United States Retail Pharmacy Market
- Competitive Landscape in the United States Retail Pharmacy Market
- Impact of COVID-19 and Demonetization on United States Retail Pharmacy Market
- Details on Current Investment in United States Retail Pharmacy Market
- Competitive Analysis of United States Retail Pharmacy Market
- Prominent Players in the United States Retail Pharmacy Market
- SWOT Analysis of United States Retail Pharmacy Market
- United States Retail Pharmacy Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the United States Retail Pharmacy Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. United States Retail Pharmacy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in United States Retail Pharmacy Market
7. United States Retail Pharmacy Market, By Type (USD Million) 2020-2033
7.1. United States Retail Pharmacy Market Size, Share and Forecast, By Type, 2020-2026
7.2. United States Retail Pharmacy Market Size, Share and Forecast, By Type, 2027-2033
7.3. Online
7.4. Offline
8. United States Retail Pharmacy Market, By Drug Type (USD Million) 2020-2033
8.1. United States Retail Pharmacy Market Size, Share and Forecast, By Drug Type, 2020-2026
8.2. United States Retail Pharmacy Market Size, Share and Forecast, By Drug Type, 2027-2033
8.3. Generic
8.4. Over the counter (OTC)
8.5. Patented
9. United States Retail Pharmacy Market, By End User (USD Million) 2020-2033
9.1. United States Retail Pharmacy Market Size, Share and Forecast, By End User, 2020-2026
9.2. United States Retail Pharmacy Market Size, Share and Forecast, By End User, 2027-2033
9.3. Equipment retail
9.4. Drug retail
9.5. Health products retail
9.6. Chemical medicine retail
9.7. Medicinal materials retail
9.8. Proprietary chinese medicine retail
9.9. Others
10. United States Retail Pharmacy Market Forecast, 2020-2033 (USD Million)
10.1. United States Retail Pharmacy Market Size and Market Share
11. United States Retail Pharmacy Market, By Region, 2020-2033 (USD Million)
11.1. United States Retail Pharmacy Market Size and Market Share By Region (2020-2026)
11.2. United States Retail Pharmacy Market Size and Market Share By Region (2027-2033)
11.3. Eastern
11.4. Western
11.5. Northern
11.6. Southern
12. Company Profile
12.1. CVS Health
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Walgreens Boots Alliance, Inc.
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Albertsons Companies
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Dirk Rossmann GmbH
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Rite Aid Corp.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. The Jean Coutu Group (PJC) Inc.
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Loblaws Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Others
13. Conclusion
14. Reference Links
15. List of Abbreviations
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.